Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial-Reference-Cited by-同舟云学术

Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial

Published:2022-05-25 Issue:2 Volume:27 Page:144-158
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripheral Nervous Sys

Author:

Veen Robin¹^ORCID,Wieske Luuk¹²,Lucke Ilse¹,Adrichem Max E.¹,Merkies Ingemar S. J.³⁴,Schaik Ivo N.¹⁵,Eftimov Filip¹

Affiliation:

1. Department of Neurology Amsterdam UMC, University of Amsterdam Amsterdam The Netherlands

2. Department of Clinical Neurophysiology St Antonius Hospital Nieuwegein The Netherlands

3. Maastricht Academic Medical Centre Maastricht The Netherlands

4. Curaçao Medical Centre Willemstad Curacao

5. Spaarne Gasthuis Haarlem The Netherlands

Funder

ZonMw

Prinses Beatrix Spierfonds

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jns.12497

Reference33 articles.

1. Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine Care

2. 196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8–10 February 2013, Naarden, The Netherlands

4. The minimum clinically important difference: which direction to take

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous immunoglobulins (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIDP): A comprehensive systematic review of clinical studies and meta-analysis;Neurological Sciences;2024-06-28

2. Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-10

3. Safety and Efficacy of Pulmonary Rehabilitation for Long COVID Patients Experiencing Long-Lasting Symptoms;International Journal of Environmental Research and Public Health;2024-02-19

4. Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives;Therapeutics and Clinical Risk Management;2024-02

5. In persons with CIDP, auto-HSCT can be conducted fully on an outpatient basis and induces significant clinical responses: A prospective study in a single center;Transplant Immunology;2023-12